Quest Diagnostics
DGX
#1069
Rank
$19.42 B
Marketcap
$173.97
Share price
-1.22%
Change (1 day)
25.23%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of March 2025 : $15.79 Billion USD

According to Quest Diagnostics 's latest financial reports the company's total assets are $15.79 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$16.15 B15.2%
2023-12-31$14.02 B9.23%
2022-12-31$12.83 B-5.69%
2021-12-31$13.61 B-2.96%
2020-12-31$14.02 B9.21%
2019-12-31$12.84 B16.72%
2018-12-31$11.00 B4.76%
2017-12-31$10.50 B3.99%
2016-12-31$10.10 B1.39%
2015-12-31$9.96 B1.07%
2014-12-31$9.85 B10.16%
2013-12-31$8.94 B-3.62%
2012-12-31$9.28 B-0.32%
2011-12-31$9.31 B9.21%
2010-12-31$8.52 B-0.42%
2009-12-31$8.56 B1.9%
2008-12-31$8.40 B-1.89%
2007-12-31$8.56 B51.3%
2006-12-31$5.66 B6.7%
2005-12-31$5.30 B26.22%
2004-12-31$4.20 B-2.27%
2003-12-31$4.30 B29.4%
2002-12-31$3.32 B13.43%
2001-12-31$2.93 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
LabCorp
LH
$17.60 B 11.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
$8.31 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
$1.60 B-89.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$63.51 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$5.54 B-64.90%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands